Skip to content

CONMED CNMD Deferred Tax Assets

Deferred Tax Assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$6.73B-20.8%
Stryker logo
StrykerSYK
$1.19B-15.5%
Boston Scientific logo
Boston ScientificBSX
$3.95B+7.5%
IAR
Integra LifeSciencesIART
$68.08M+79.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.09M-56.0%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: CONMED’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's deferred tax assets?
CONMED (CNMD) reported deferred tax assets of $13.31M in Q4 2025.
How has CONMED's deferred tax assets changed year-over-year?
CONMED's deferred tax assets increased by 20.2% year-over-year, from $11.07M to $13.31M.
What is the long-term trend for CONMED's deferred tax assets?
Over 5 years (2020 to 2025), CONMED's deferred tax assets has grown at a 14.2% compound annual growth rate (CAGR), from $6.84M to $13.31M.
What does deferred tax assets mean?
Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.